Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.0K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

839
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
839
Types of Intermediate Filaments01:31

Types of Intermediate Filaments

3.7K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Advances in the Pharmacological Management of Pediatric Spondyloarthritis.

Paediatric drugs·2026
Same authorSame journal

Nailfold Videocapillaroscopy in Pediatric Rheumatology: Established Roles, Emerging Applications, and Future Perspectives.

Balkan medical journal·2026
Same author

Tuberculosis Diagnosis and Prevention in Children on Biological Treatment: Clinical Challenges and Considerations.

Turkish archives of pediatrics·2026
Same author

Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study.

Pediatric rheumatology online journal·2026
Same author

A multicentre study for clinical phenotype prediction in juvenile dermatomyositis: categorical principal component analysis-based hierarchical clustering.

Reumatologia·2026
Same author

Evidence of docosahexaenoic acid deficiency in maple syrup urine disease: insights from plasma long-chain polyunsaturated fatty acid status.

European journal of clinical nutrition·2026

Related Experiment Video

Updated: Jul 31, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.4K

Type I Interferonopathies in Childhood.

Fatih Haşlak1, Elif Kılıç Könte1, Esma Aslan1

  • 1Department of Pediatric Rheumatology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.

Balkan Medical Journal
|May 10, 2023
PubMed
Summary

Type 1 interferonopathies are rare genetic disorders causing autoimmune and autoinflammatory conditions due to increased type 1 interferons (IFN). Diagnosis requires genetic sequencing, with JAK inhibitors showing promise for treatment.

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

19.4K

Related Experiment Videos

Last Updated: Jul 31, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.4K
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

19.4K

Area of Science:

  • Genetics
  • Immunology
  • Rare Diseases

Background:

  • Type 1 interferonopathy encompasses inborn disorders characterized by autoimmunity and autoinflammation.
  • These conditions result from genetic mutations leading to upregulated type 1 interferons (IFN).
  • Common manifestations include vasculitic skin changes, systemic inflammation, and neurological issues.

Purpose of the Study:

  • To provide an overview of type 1 interferonopathies, including their genetic basis, clinical features, diagnostic approaches, and emerging treatments.
  • To highlight the role of IFN signature and the necessity of genetic sequencing for definitive diagnosis.
  • To discuss current and potential therapeutic strategies for these rare disorders.

Main Methods:

  • Review of existing literature on type 1 interferonopathies.
  • Analysis of common clinical and genetic features.
  • Evaluation of diagnostic tools, including IFN signature and whole exome sequencing (WES).
  • Discussion of therapeutic interventions and ongoing research.

Main Results:

  • Type 1 interferonopathies share a common pathway disturbance with characteristic clinical presentations.
  • IFN signature is a sensitive but not specific diagnostic marker.
  • Whole exome sequencing (WES) is crucial for accurate diagnosis.
  • JAK inhibitors demonstrate significant therapeutic potential, with other treatments and antibody therapies under investigation.

Conclusions:

  • Type 1 interferonopathies represent a distinct group of genetic disorders requiring precise diagnosis through genetic sequencing.
  • Targeted therapies, particularly JAK inhibitors, offer promising treatment avenues.
  • Further clinical trials are needed to establish optimal treatment regimens.